Skip to main content
. 2022 Dec 2;30:62. doi: 10.1186/s13049-022-01044-y

Table 2.

Patients’ characteristics in subgroups

INVOS n = 13 Root O3 n = 14
ROSC n = 7 nROSC n = 6 P ROSC n = 7 nROSC n = 7 P
Age, (mean ± CI*) 69.6 (53-86.2) 60.5 (52.7–68.3) 0.44 62 (38.7–85.3) 77 (62.2–91.8) 0.33
Male, n( %*) 4 (66.7) 3 (50) 1.00 5 (100) 4 (66.7) 0.46
Bystander CPR, n( %) 4 (57.1) 6 (100) 0.19 6 (85.7) 6 (85.7) 1.00
No flow time, min (mean ± CI) 0.8 (0.4–1.2) 1.3 (0.7–1.9) 0.20 1.2 (0,3-2.1) 2.8 (0-5.7) 0.36
Shockable rhythm, n (%) 2 (28.6) 2 (33.3) 1.00 5 (71.4) 2 (28.6) 0.29
Time to ambulance, min (mean ± CI) 12.8 (9.9–15.7) 7.8 (5-10.6) 0.03 10.6 (8-13.2) 11.4 (7.3–15.5) 0.73
Time to hospital, min (mean ± CI) 43.3 (32-54.6) 50.0 (42.5–57.5) 0.29 47.3 (35.2–59.4) 50.2 (43.2–57.2) 0.71
Adrenalin, mg (mean ± CI) 2.7 (1.2–4.2) 5.5 (3.5–7.5) 0.06 5 (3–7) 4.9 (2.6–7.2) 0.93
Dilatated pupils, n (%) 3 (42.9) 4 (66.7) 0.59 5 (71.4) 6 (100) 0.46
rSO2, %(mean ± CI**) 54 (40.3–67.7) 28 (12.3–43.7) 0.04 50 (46.5–53.5) 41 (36.3–45.7) 0.02
ETCO2, kPa (mean ± CI***) 5.1 (3.3–6.9) 4.6 (2.8–6.4) 0.68 3.3 (2.8–3.8) 2.6 (1.9–3.3) 0.19

*Number of patients in the INVOS group 12 and in ROOT O3 group 11. **Number of patients in INVOS group 11, ROOT O3 group 13. *** Number of patients in INVOS group 11, in ROOT O3 group 10 patients